在特殊人群中使用dupilumab治疗亚托皮炎:一系列案例研究
Ersilia Tolino1, Nevena Skroza1, Antonio Di Guardo2,3
1Unit of Dermatology, Department of Medical-Surgical Science and Biotechnologies, Sapienza University of Rome, A. Fiorini Hospital, Terracina, Latina, Italy.
Clinical, cosmetic and investigational dermatology
|November 5, 2025
概括
杜皮卢马布在特殊人群 (包括移植患者和癌症患者) 中有效治疗了亚托皮炎 (AD),没有任何不良影响. 需要进一步的研究来确认其在这些群体中的长期安全性和有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托皮炎 (AD) 是一种慢性炎症性皮肤疾病,其特点是皮肤屏障缺陷和T helper (Th) 2介导的炎症.
- 针对IL-4和IL-13的生物药物杜皮卢马布 (Dupilumab) 已被批准用于AD和其他2型炎症性疾病.
- 杜皮卢马布在患有复杂并发性疾病的特殊群体 (SP) 的安全性和有效性尚未得到充分证实.
研究的目的:
- 评估dupilumab在特殊人群中治疗亚托皮性皮炎 (AD) 的安全性和有效性.
- 评估接受dupilumab治疗的SP患者的临床结果和不良事件.
主要方法:
- 分析了12名用杜皮卢马布治疗的SP患者的回顾性病例系列.
- 包括的病例包括一个移植接受者,一个转移性黑色素瘤患者,一个非功能性垂体腺瘤患者和一个患有多发性硬化症 (MS) 的个人.
- 临床数据和结果使用已建立的指数进行评估.
主要成果:
- 在所有评估的病例中,dupilumab显著改善了AD症状.
- 没有报告与dupilumab治疗相关的副作用.
- 在研究期间,SP患者的潜在疾病没有复发.
结论:
- 杜皮卢马布在特殊人群中显示出作为AD安全有效治疗的潜力.
- 需要仔细监测和进一步的大规模研究,并进行延长的随访,以确认SP与并发症的安全性和有效性.
- 个性化治疗策略和持续的研究对于优化复杂病史患者的治疗结果至关重要.
相关概念视频
01:30Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
01:26COPD: Management Using Bronchodilators and Corticosteroids
713
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
713
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K